United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

almus pharmaceuticals ltd - clonazepam - oral tablet - 2mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

star pharmaceuticals ltd - clonazepam - oral tablet - 2mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

besins healthcare (uk) ltd - progesterone - oral capsule - 200mg

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

bushu pharmaceutical, ltd. - lurasidone hydrochloride (unii: o0p4i5851i) (lurasidone - unii:22ic88528t) - lurasidone hydrochloride 40 mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

thornton & ross ltd - levomenthol; squill tincture; liquorice liquid extract - oral solution - 800microgram/1ml ; 120microlitre/1ml ; 25microlitre/1ml

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - clonazepam - oral tablet - 2mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - clonazepam - oral tablet - 2mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - clonazepam - oral tablet - 2mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - clonazepam - oral tablet - 2mg

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

remedyrepack inc. - lurasidone hydrochloride (unii: o0p4i5851i) (lurasidone - unii:22ic88528t) - latuda is indicated for: latuda is indicated for: - treatment of adult and adolescent patients (13 to 17 years) with schizophrenia [see clinical studies ( 14.1)] . - monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies ( 14.2)] . [see clinical studies ( 14.2)] - adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar i disorder (bipolar depression) [see clinical studies ( 14.2)] . - known hypersensitivity to lurasidone hcl or any components in the formulation. angioedema has been observed with lurasidone [see adverse reactions ( 6.1)] . - strong cyp3a4 inhibitors (e.g., ketoconazole, clarithromycin, ritonavir, voriconazole, mibefradil, etc.) [see drug interactions ( 7.1)]. - strong cyp3a4 inducers (e.g., rifampin, avasimibe, st. john's wort, phenytoin, carbamazepine, etc.) [see drug interactions ( 7.1)]. pregnancy expo